The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Intra-Tumor Heterogeneity in Primary and Metastatic HCC

David J. Pinato, MD, PhD
Published Online:2:44 PM, Tue July 11, 2017

David J. Pinato, MD, PhD, NIHR Academic Clinical Lecturer in Medical Oncology, resident, Royal Brompton Hospital and Imperial College London, discusses an analysis of intra-tumor heterogeneity in the regulation of immune-tolerogenic pathways in primary and metastatic hepatocellular carcinoma (HCC). 
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.